CHDI x Proteros Biostructures
Dedicated to developing safe, effective therapeutics for Huntington’s Disease, CHDI are a privately-funded, nonprofit who fund and collaborate with academic researchers, biotechs, and pharmaceutical companies, on a global scale.
As a nonprofit organization, CHDI act as a ‘collaborative enabler’ ensuring access to resources such as clinical data and bio samples, assays, reagents, antibodies, and more, are available to any research teams, removing the typical barriers they face. We are in a partnership with CHDI to help them with this process.
